<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03453788</url>
  </required_header>
  <id_info>
    <org_study_id>LETSGOpilot</org_study_id>
    <nct_id>NCT03453788</nct_id>
  </id_info>
  <brief_title>Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology</brief_title>
  <acronym>LETSGO</acronym>
  <official_title>Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sorlandet Hospital HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Agder</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sorlandet Hospital HF</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study is evaluating a new smartphone application named the LETSGO app. The LETSGO
      app is designed to promote empowerment in patients after treatment for gynecological cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gynecological cancer treatment is increasingly successful, resulting in a rising number of
      cancer survivors. Many gynecological cancer survivors may experience late side effects from
      their cancer treatment. In addition, evidence is accumulating that an active lifestyle may
      increase empowerment and may positively influence well-being after cancer treatment. Through
      the LETSGO smartphone app, women treated for gynecological cancer will get access to
      individualized posttreatment information on side effects as well as tailored physical
      activity advices in order to assume more responsibility for achieving the best outcomes from
      her care. The participants will also regularly answer patient reported outcomes regarding
      possible recurrence though the app. As a first step the smart-phone application will be
      pilot-tested.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2018</start_date>
  <completion_date type="Anticipated">March 26, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 26, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective cohort study with reference group.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction with LETSGOapp</measure>
    <time_frame>8 months</time_frame>
    <description>Evaluate satisfaction with app through patient interviews</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluate the patient recruitment rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability of goal setting</measure>
    <time_frame>8 months</time_frame>
    <description>Evaluate acceptability of goalsetting through changes in Activity level</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Gynecologic Cancer</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Alternating follow-up visits by nurse and doctor. In the nurse-led consultations, the patients will be introduced to the smartphone LETSGOapp with access to information on cancer treatment and side effects, physical activity advice. Two-monthly assessment of 12 symptoms that may represent relapse through the app.The patients will fill in an electronic questionnaire package at baseline, 3, and 6 months after treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reference group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Regular hospital follow-up.The patients will fill in an electronic questionnaire package at baseline, 3, and 6 months after treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LETSGO app</intervention_name>
    <description>LETSGO pilot test Group will test LETSGO app and partially nurseled follow-up</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed and treated for gynecological cancer who will be followed up at the
             gynecological outpatient clinic in Kristiansand or Arendal

          -  No cognitive barriers.

        Exclusion Criteria:

          -  &lt; 18 years

          -  Not able to read Norwegian
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frode Gallefoss</last_name>
    <role>Study Chair</role>
    <affiliation>Chief of Research Department, SÃ¸rlandet Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ingvild Vistad, PhD</last_name>
    <phone>4797532316</phone>
    <email>ingvild.vistad@sshf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sveinung Berntsen, PhD</last_name>
    <phone>4790989765</phone>
    <email>sveinung.berntsen@uia.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sorlandet Hospital</name>
      <address>
        <city>Kristiansand</city>
        <state>Vest Agder</state>
        <zip>4604</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingvild R Vistad, MD, PhD</last_name>
      <phone>47-380 73000</phone>
      <phone_ext>8482</phone_ext>
      <email>ingvild.vistad@sshf.no</email>
    </contact>
    <contact_backup>
      <last_name>Mette Skorstad, MD</last_name>
      <phone>47-380 73000</phone>
      <email>mette.skorstad@sshf.no</email>
    </contact_backup>
    <investigator>
      <last_name>Ingvild Vistad, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2018</study_first_submitted>
  <study_first_submitted_qc>March 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>follow up</keyword>
  <keyword>side effects</keyword>
  <keyword>smartphone app</keyword>
  <keyword>physical activity</keyword>
  <keyword>empowerment</keyword>
  <keyword>patient reported outcomes</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>This is a pilot study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

